For­bion's new €75M fund; Cara Ther­a­peu­tics to cut work­force af­ter tri­al fail­ure

Plus, news about Cin­clus Phar­ma, Bio­phytis and Blan­ver:

For­bion’s new fund: The Dutch VC firm’s BioE­con­o­my Fund I closed €75 mil­lion …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.